+Search query
-Structure paper
| Title | TNG961 is a selective oral HBS1L molecular glue degrader for the treatment of FOCAD-deleted cancers. |
|---|---|
| Journal, issue, pages | Cancer Discov, Year 2026 |
| Publish date | Apr 19, 2026 |
Authors | Hilary E Nicholson / Douglas A Whittington / Frank J Bruzzese / Katherine Lazarides / Lauren Catherine M Martires / Matthew R Tonini / Helena N Jenkins / Minjie Zhang / Preksha Shahagadkar / Charlotte B Pratt / Kimberly J Briggs / Patrick McCarren / Alice Tsai / Madhavi Bandi / Chengyin Min / Alan Huang / Hongxiang Zhang / Samuel R Meier / Binzhang Shen / Yi Yu / Colin Liang / Yong Liu / Teng Teng / John Zhang / Adam Crystal / William D Mallender / Xinyuan Edward Wu / John P Maxwell / Jannik N Andersen / ![]() |
| PubMed Abstract | When tumor suppressor genes are lost through chromosomal deletion, deletion of adjacent genes can generate therapeutic vulnerabilities. MTAP is frequently co-deleted with the Chr9p21 tumor suppressor ...When tumor suppressor genes are lost through chromosomal deletion, deletion of adjacent genes can generate therapeutic vulnerabilities. MTAP is frequently co-deleted with the Chr9p21 tumor suppressor gene CDKN2A, creating synthetic lethal dependency on PRMT5. Telomeric to MTAP lies FOCAD, whose loss induces dependency on the HBS1L/PELO ribosome-rescue complex for translational maintenance. FOCAD is deleted in ~1/3 of MTAP-deleted cancers. We screened an IMiD-focused diversity library and identified a weak hit that bound cereblon, promoted HBS1L-CRBN-compound complex formation, and induced E3-ligase-dependent HBS1L ubiquitination and degradation. Guided by cryo-EM structures and proteome selectivity we developed TNG961, a potent, selective HBS1L degrader that disrupts the HBS1L/PELO complex, inducing translational arrest, unfolded protein response activation, and growth inhibition in FOCAD-negative models. Oral administration of TNG961 regresses FOCAD-negative xenografts, including PRMT5 inhibitor-refractory models, establishing HBS1L degradation as a strategy to exploit FOCAD loss and supporting clinical evaluation of TNG961 as a first-in-class precision oncology therapeutic. |
External links | Cancer Discov / PubMed:42001523 |
| Methods | EM (single particle) |
| Resolution | 2.6 - 2.9 Å |
| Structure data | EMDB-75038, PDB-10ay: EMDB-75840, PDB-11mr: |
| Chemicals | ![]() PDB-1c4s: ![]() ChemComp-ZN: ![]() PDB-1c9w: |
| Source |
|
Keywords | CYTOSOLIC PROTEIN / FOCAD / ribosome / PELO / ubiquitin |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links






homo sapiens (human)
Keywords